| MCO |
Report |
Adjusted diluted EPS |
BEAT |
pred ~$4.30 vs. cons $4.25 |
MEDIUM |
| MCO |
Report |
MIS revenue |
BEAT |
pred ~$1.215B vs. cons $1.201B |
MEDIUM |
| MCO |
Report |
MA ARR |
IN-LINE |
pred ~$3.620B vs. cons $3.592B |
MEDIUM |
| MCO |
Guide |
FY26 adjusted diluted EPS |
UNCHANGED |
guide $16.40-$17.00 vs. cons $16.78 |
MEDIUM |
| MCO |
Guide |
FY26 MCO revenue growth |
UNKNOWN |
guide high-single-digit growth; dollar comparison unavailable |
LOW |
| MCO |
Guide |
Q3 adjusted diluted EPS |
UNKNOWN |
no verified company range before the report vs. cons $4.38 |
LOW |
| MCO |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| MCO |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — implicit Q4 estimate risk |
LOW |